Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 2Recruiting 2Not yet recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 1871Triple Negative Breast Neoplasms 126Neoplasms 74Ovarian Neoplasms 56Neoplasm Metastasis 55Colorectal Neoplasms 54Prostatic Neoplasms 53Lung Neoplasms 51Stomach Neoplasms 45Pancreatic Neoplasms 43Motor Activity 41Colonic Neoplasms 41Lymphedema 35Breast Cancer Female 32Advanced Breast Cancer 32Carcinoma, Non-Small-Cell Lung 31Endometrial Neoplasms 28Melanoma 27Breast Diseases 26Head and Neck Neoplasms 25Cardiotoxicity 25HER2-positive Breast Cancer 22Uterine Cervical Neoplasms 21Brain Neoplasms 21Breast Cancer Lymphedema 20Pain 19Fatigue 19Esophageal Neoplasms 19Breast Neoplasms, Male 19Urinary Bladder Neoplasms 18

Interventions

Lapatinib 1Injections 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × HER2-positive Advanced Breast Cancer × Breast × Clear all
NCT04963608 2021-07-15

RWS of Inetetamab HER2 Positive Advanced Breast Cancer

Shandong Cancer Hospital and Institute

Unknown
100 enrolled
Breast

HER2-positive Advanced Breast Cancer

NCT04185649 2019-12-04

The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer

Bio-Thera Solutions

Phase 3 Unknown
410 enrolled
Breast

HER2-positive Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡